If interferon is produced by the gut-associated lymphoid tissue of healthy rabbits under normal conditions and is not all bound in situ, it may spill over and be detectable in lymph. We therefore measured antiviral activity in lymph and plasma simultaneously. We found that antiviral activity was consistently measurable in abdominal and thoracic lymph but not in plasma or in the lymph collected from the hind leg duct. The antiviral activity was neither due to lipoproteins, nor immunoglobulins, nor to cell-produced viral inhibitors other than interferons. Extensive characterization of the antiviral activity indicated that the inhibitor is either rabbit interferon gamma or an acid-labile interferon alpha or a mixture; appropriate antisera will be necessary to resolve this uncertainty. The results support the view of the existence of a physiological interferon response.
INTRODUCTION
It has been suggested that interferon (IFN) is produced continuously in health by the mucosal lymphoid tissue exposed to a number of xenobiotic agents which may function as IFN inducers (Bocci, 1981a) . Among the putative five sites (gut, bronchial tree, epidermis and mucosae, internal immune system and placenta) discussed in detail elsewhere (Bocci, 1982) , the gutassociated lymphoid tissue (GALT) is probably the most likely to yield IFN. It was suggested that the physiological IFN response would consist of a strictly localized production of IFN with no significant leakage into the general circulation: even, if there is some leakage, antiviral activity (AA) is scarcely detectable in normal plasma, probably because IFN has a very high turnover rate (Bocci, 1981b) .
Experimental evidence in favour of such a physiological response is scanty, indirect and controversial. Enzymic activities [protein kinase and (2'-5')oligo-A synthetase] analogous to those found in IFN-treated patients, were detected in normal human plasma by Hovanessian et al. (1981) and in peripheral blood mononuclear cells (PBMC) of healthy subjects by Schattner et al. (1981) . Lebon et al. (1982) measured trace levels of IFN alpha in normal human amniotic fluid, whereas Cesario et al. (1981) could only detect components inactivating IFN beta and antibodies against herpes simplex virus and cytomegalovirus. measured levels of AA corresponding to less than 4 interferon units per ml in normal plasma, and correspondingly 94 ~ of PBMC did not show an antiviral state. Finally, on the positive side, Fischer et al. (1982) claimed that circulating large granular lymphocytes (probably natural killer cells) isolated from normal human blood, produced IFN spontaneously in vitro.
We reasoned that, as the GALT is a potential site of physiological production of IFN, it may be present in the pericellular fluid of the induced cells and, in addition to being utilized locally, may spill over into the intestinal lymph. Thus, it appeared worthwhile to study whether AA was measurable in the lymph, plasma and urine of normal rabbits.
METHODS

Animals.
Adult male rabbits of several breeds (White New Zealand; Californian, Hungarian) 3 to 4 months old, weighing between 2.2 and 3.0 kg were collected from five different breeders throughout 16 months. Animals had been vaccinated, after weaning, against myxomatosis infection. The rabbits were housed under conventional 0022-1317/84/0000-5741 $02.00 © 1984 SGM v. BOCCI AND OTHERS conditions in a well-aerated room with pellets and water available ad libitum. Animals were healthy and showed no sign of infectious diseases or parasites. At the end of an experiment, an autopsy was carried out on each animal to check on any macroscopic change. Absence of virus infections was assessed indirectly: sterile blood collected from the aorta was incubated at 37 °C for 24 h and then the separated plasma was tested for IFN activity; this was below 3 IU in all animals but two (the data from these two were discarded). Although this is a very primitive test, we felt it could be useful to help detection of a latent or incipient virus infection. We are trying to improve the test by incubating buffy coat cells for a longer time. Particularly at the beginning of the study, a dose of 3 to 5 ml olive oil was administered orally to the rabbits 5 to 6 h before operation in order to facilitate the location of the abdominal lymphatic duct.
Surgery. Permanent cannulation of the main lymphatic duct was carried out about I cm above the cysterna chyli via a midventral laparatomy in Nembutal (30 mg/kg body weight)-anaesthetized animals using aseptic surgical techniques (Bollman et al., 1948; Jakab et al., 1980) . A polythene catheter (usually a Portex PP 50) was passed through the abdominal wall for collection of lymph.
Collection of samples and separation of lipoproteins from lymph. Blood and lymph samples were collected in dry heparin (5 IU/ml of the sampie) for variabie periods not exceeding 6 h. Urine was collected with a syringe from the bladder at the end of the experiment and exhaustively dialysed against saline in the cold before testing. Chylomicrons were separated routinely from lymph by centrifuging samples at 105000g for 1 h at 4 °C in a Beckman model L5-65 ultracentrifuge. Removal of all lipoproteins was obtained by flotation, carried out by adding a 2.63 M-NaC1-2.97 M-KBr solution to the previously clarified lymph to achieve a final density of 1.210 g/ml according to the technique of Havel et al. (1955) . The specific gravity of lymph was 1.024 + 0-003. After centrifugation of the sample at 105 000 g for 24 h at 4 °C, it had separated into three fractions, of which the top one contained practically all the lipoproteins. The middle and bottom fractions progressively contained less lipid.
IFN assay. The microplaque reduction assay described by Langford et al. (1981) was used throughout for the titration of rabbit IFN using both primary newborn rabbit kidney cells and rabbit kidney line cells (RL; Laboratoires Eurobio, Paris, France). Briefly, threefold dilutions of samples in Eagle's minimum essential medium (EMEM) supplemented with 2~ foetal calf serum (FCS; Seromed, Miinchen, F.R.G.) were added to cell monolayers. After 16 to 18 h incubation, the medium was removed by inversion and monolayers were carefully washed three times with EMEM without FCS for removing interfering substances. Monolayers were then infected with about 60 plaque-forming units (p.f.u.) of vesicular stomatitis virus (VSV, Indiana strain) in 1% FCS-EMEM. Samples were tested at least in duplicates. In the later experiments we also used encephalomyocarditis virus (EMCV) as recommended by WHO (1982) . The international reference preparation (IRP) of rabbit serum IFN (RalFN) induced with Newcastle disease virus (NDV) (G-019-902-528 with a defined potency of 4-0 log10 IU per vial) when reconstituted in 1-0 ml had a geometric mean of 3.75 log10 IU/ml (S.D. = 0.26 ; n = 12). In each assay an internal laboratory standard (NDV-induced RalFN) was included, which when calibrated against the IRP in 10 titrations had a potency of 5.39 log~o IU/ml (S.D. = 0.27). As previously shown by Finter (1969) , we found that the portion of the curve relating the percentage of VSV inhibition determined by plaque count to the log IFN dilution was linear between 30~ and 75~.
Since as yet there is no IRP of RalFN of the gamma type we prepared a laboratory reference preparation of RalFN gamma in our laboratory: rabbits were sensitized with BCG, stimulated intravenously with purified protein derivatives of tuberculin (PPD) 4 weeks later and blood was withdrawn after 2 h (G. P. Pessina et al., unpublished method).
However, dose response curves of three different preparations gave different slopes in comparison to the NDVinduced IRP RalFN so that AA induced by PPD could not be calibrated against the NDV-induced IRP RalFN and titres are reported as laboratory units. This standard (assumed to be IFN gamma) in 20 titrations had a potency of 2.40 log10 laboratory units/ml (S.D. = 0.18). Titres remained stable for months when samples were stored at -20 °C.
Characterization oflFN. Characterization of IFN was carried out according to standard procedures, namely acidification of samples at pH 2 followed by neutratization, heating at 56 °C for 1 h, dialysis, ultracentrifugation, proteolytic and other enzymic treatments and addition of cycloheximide (10 ~tg/ml) 6 h before IFN.
Rabbit lymph, plasma and urine samples were tested also on other cell lines (WISH, HEp-2, Ratec, L 929, MDBK and chick embryo fibroblasts).
Cell-produced viral inhibitors (CV1) assay. This was carried out as described by Baron & McKerlie (1981) and Hughes et al. (1981) . CVI were titrated in L 929, WISH and HEp-2 cells grown to confluence in Microtest plates. Serial dilutions were made by mixing 0.1 ml of the sample with 0-1 ml EMEM containing 2~ FCS in duplicate wells followed by addition of 25 vtl of either VSV or vaccinia virus or poliovirus type 1 (30 to 50 p.f.u.). After 1.5 h adsorption at 37 °C in a 5 ~ CO2 atmosphere, the remaining inhibitor and unadsorbed virus were decanted and the cultures overlaid with 0.5 ~o methylcellulose and incubated overnight. When plaques were visible microscopically, cells were stained with a 1 ~ crystal violet solution in 20~ methanol. The inhibitory titre was calculated as the highest dilution of the sample that inhibited 50~ of viral plaques in the continuous presence of the inhibitor.
Characterization of CVL Characterization of CVI was carried out according to Baron & McKerlie (1981) , namely (i) titration of the samples against vaccinia, VSV and poliovirus type 1 to demonstrate the broad antiviral activity of the inhibitors; (ii) demonstration of the absence of irreversible neutralization of viruses by the inhibitors; (iii) demonstration that the inhibitors act extracellularly at the level of virus attachment and penetration; (iv) trypsin inactivation of inhibitors; (v) heating of the CVI at 100 °C for 1 h; (vi) dialysis for 1 day at 2 °C.
VSV-neutralizing activity. Virus-neutralizing activity was assessed using VSV. The assay was performed by serially diluting plasma and lymph samples with an equal volume of diluent containing about 70 p.f.u, of VSV and incubating at 37 °C for 1 h. The VSV-biological sample mixture was left in the cold for 1 h and then tested in microtitre plates containing RL cells. The neutralizing titre was considered to be the dilution of lymph or plasma that demonstrated a 50% plaque reduction. A rabbit anti-VSV antiserum (a dilution of 1:5120 neutralized 100 p.f.u, of VSV) was used to make sure that removal of the sample followed by three washings (with EMEM without FCS) of the plates effectively eliminated any antibody interference within the IFN assay.
Bacterial and endotoxin determinations. All biological samples were sterile according to standard bacteriological tests; most of the samples were tested also for the possible presence of endotoxin by the Limulus amoebocyte lysate (LAL) test. Detection levels ranged among different kits between 0-025 and 0.05 ng/ml.
Chemical determinations. Protein concentration was determined by the method of Gornall et al. (1949) with bovine serum albumin as a standard. Lymph had to be clarified by ultracentrifugation, because the simple addition of an equal volume of 2% sodium deoxycholate solution gave spurious values. Lipid concentration was measured by the sulphophosphovanillin reaction, with a test kit which measured total lipids (Boehringer, cat. no. 124303).
RESULTS
Interpretation of assay results
As described below, abdominal lymph from healthy rabbits always contained AA which was characterized as due to a content of interferon, probably of gamma type, or a mixture of different interferons. However, the dose-response curves for the IRP of rabbit serum IFN NDV-induced and for the IFN in rabbit lymph were parallel when tests were carried out in RL cells challenged with VSV, but not parallel when tested in primary rabbit kidney cells challenged with VSV. Also, assays carried out with RL cells were about 8 times less sensitive than assays with primary rabbit cell cultures. These data clearly indicate that the IRP of rabbit serum IFM is not appropriate for testing rabbit lymph IFN which, as described below, is probably a gamma IFN or a mixture of different IFN types. In view of these uncertainties and the absence of suitable reagents to resolve the problem, we have expressed the AA activity in rabbit lymph in this paper in laboratory units, i.e. as the reciprocal of the endpoint dilutions achieved in assays whose general sensitivity was monitored by means of the IRP of rabbit serum IFN.
Measurement and characterization of antiviral activity in the abdominal and thoracic lymph of normal rabbits
The amounts of AA found in the abdominal lymph of 15 normal rabbits at different times during a period of 4 h of lymph collection are shown in Fig. 1 .
In order to exclude the possibility that the oil administration had any influence on the observed AA in lymph, abdominal lymph was collected from normally fed animals and compared to that obtained after oil feeding. Mainly because of the lack of chylomicrons, the former was 'clear' while the latter had a 'milky' appearance. Table 1 shows that both the 'milky' and the 'clear' abdominal lymph samples as well as 'clear' lymph withdrawn from the thoracic duct had very similar AA. On the other hand, lymph collected from the hind leg lymphatic vessels did not have any AA.
Removal of chylomicrons by ultracentrifugation clarified the lymph but did not affect the AA titre. However, prolonged ultracentrifugation of the lymph raised to a final density of 1.21 g/ml yielded a sample of lymph (bottom fraction) almost free of lipids, enriched in proteins and with slightly increased AA. This result was very reproducible and suggested that AA molecules have a specific gravity near to 1.21 and tend to concentrate in the bottom fraction of this system. Furthermore the top fraction of lymph containing all lipoproteins showed a decrease of AA, even though the specific activity was apparently increased. It is worthwhile mentioning that after simultaneous collection, titration of hind leg, abdominal lymph and plasma from two normal rabbits detected AA only in abdominal lymph.
It was shown that the observed AA was not due to anti-VSV antibodies because the washing procedure used in the assay before VSV addition removed antibodies completely: addition of a potent anti-VSV antiserum to rabbit plasma did not yield any AA after three washings, whereas simple removal of the medium was not as effective. It should be noted that rabbit plasma and lymph samples invariably contained anti-VSV antibodies ( Table 2 ) that certainly could have interfered with the IFN assay if they had not been completely removed.
Normal body fluids contain a number of non-specific virus inhibitors (CVI) other than IFN, and L. Paulesu et al. (unpublished results) found CVI levels in rabbit lymph and plasma corresponding to 50 U/ml. It is therefore important to emphasize that CVI could not be measured in our IFN assay, as we proved that removal of the sample and the three successive washings effectively eliminated any CVI interference. Moreover, lymph CVI resemble IFN in that they t Added at 10/.tg/ml to the test ceils 6 h before addition of putative IFN samples. are not dialysable and differ in that they are acid-stable, heat-stable (100 °C for 1 h), resistant to common proteolytic enzymes and protect L 929, HEp-2 and WISH cells from vaccinia, VSV, and poliovirus type 1. As bacterial endotoxins are well-known IFN inducers, most of the samples were tested for the presence of endotoxin by the LAL test. All samples collected from the different rabbits were either negative or the endotoxin content was below 0.25 ng/ml.
Finally we tried to characterize the AA. Table 3 shows that, by standard tests, the AA was due to IFN. Table 4 shows that lymph IFN displayed a remarkable cross-species activity particularly on human cell lines. The finding was unexpected because it is known (and Table 4 confirms the result) that RalFN induced by NDV (most likely a mixture of acid-stable alpha "q. BOCCI AND OTHERS and beta IFNs) is inactive in human cells. However the RalFN induced by PPD in BCGsensitized rabbits (presumably an IFN gamma and confirmed by preliminary characterization) displayed a cross-species activity fairly similar to that exhibited by lymph IFN. It is unfortunate that antisera to distinguish rabbit IFN types are not yet available. DISCUSSION We have shown that abdominal lymph withdrawn from normal rabbits apparently free of bacterial, viral and parasitic infections consistently possesses AA but that this is absent in hind leg lymph, plasma and urine collected at the same time. At the beginning of the study we used routinely rabbit cell lines for assay and measured only very little AA. This posed serious problems in terms both of reproducibility and interpretation of the results. Thus the use of more IFN-sensitive primary kidney cells from newborn rabbits was not merely advantageous but actually made the investigation possible.
In trying to prove or disprove the existence of a physiological IFN response, our hypothesis was that we would find very low titres of AA for the following reasons. (i) The stimuli acting as IFN inducers would correspond to various foreign agents encountered in everyday life which, although in principle pathogenic, are considered as 'physiological' stimuli.
(ii) Typical responding cells would be the subepithelial lymphoid tissue situated at the portals of entry, in strategic positions to block inward penetration of toxins or pathogenic inducers. (iii) At any time, there would be only a few stimulated cells releasing IFN (as well as other lymphokines according to the concept of a paracrine secretion) so that most if not all IFN would be bound in the extracellular fluid to circulating cells. Also, should IFN reach the general circulation, it could be rapidly eliminated by a very efficient catabolic system (Bocci, 1981 b) .
Of the five sites hypothesized as candidates for a physiological IFN response (Bocci, 1982) , we now consider that the most likely is the GALT. On the assumption of a strictly localized production, it was reasonable to expect either very low or no AA in lymph formed in the abdominal organs. Thus the finding of some AA in abdominal lymph, but not in plasma or in hind leg lymph, was interesting: it suggested that the GALT of healthy animals which must come into contact with alimentary lectins, heterologous proteins and various other xenobiotic agents continuously, does indeed produce small amounts of AA.
However, since the low levels of AA measured could result from various factors other than IFN, we characterized the AA as extensively as possible. First, it was essential to see if the high lipoprotein content of the lymph played any role since Halonen et al. (1974 ), Montelaro et al. (1979 and more recently Seganti et al. (1982) have shown that serum lipoproteins, and especially low density lipoproteins, can inhibit virus adsorption to host ceils. We found that removal of chylomicrons as well as lipoproteins by the method of Havel et al. (1955) did not change the AA of the lymph. Indeed, we showed that the top fraction of lymph containing all lipoproteins had a slightly lower AA than the bottom fraction which contained the bulk of albumin and had a lipid content (most probably fatty acids bound to albumin) as low as 3 ~.
Second, healthy immunized rabbits maintained in conventional conditions consistently had levels of antibody to VSV that were higher in plasma than in lymph. However, we proved that during the IFN assay, removal of the samples whether of plasma or lymph and with or without addition of antiserum to VSV, followed by three washings before virus challenge, eliminated completely any interference by immunoglobulin.
Third, Kumar & Baron (1981-82) have reviewed the evidence that CVI are present, often with high titres, in body fluids, particularly colostrum and milk (Matthews et al., 1976) . We have now measured titres of CVI of about 50 U/ml in lymph and plasma. However we do not believe that CVI interfere with the IFN assay : to inhibit virus attachment, CVI must be present at the time of virus challenge, whereas in the IFN assay the biological sample is removed and the cell monolayer washed thoroughly. Moreover, as indicated by our results, we could apply other important criteria (Baron & McKerlie, 1981) to show that CVI are not responsible for the observed AA.
Having shown that the lymph was free from detectable endotoxin and bacterial contamination, we characterized this AA. As far as we can judge from its properties (Tables 3 and 4 ), it appears to be due to IFNs. We reached this latter conclusion mostly on the basis of its heat-and acid-lability and on its spectrum of cell species activity which closely resembled that due to either a putative acid-labile interferon alpha or RalFN gamma or both. This agrees with the postulated nature of the prevalent type of IFN likely to be found in the physiological response, but is not a definitive demonstration. There are many stimuli in the intestinal lumen which could induce production of IFN alpha, and the recent finding of an acid-labile IFN alpha (DeStefano et al., 1982) must be borne in mind. Final proof that the lymph inhibitor is indeed an IFN or IFNs must await the availability of specific antisera for neutralization. Nonetheless, we believe that the present results show, for the first time, that the GALT produces under normal conditions small amounts of IFN (and possibly other lymphokines) which are detectable in the abdominal lymph but not in plasma.
If IFN is produced by the GALT, what is its role under physiological conditions? It is now clear that the interferons have many functions, and we believe that, together with many other defensive factors, it has an important role in maintaining health. Further work will be needed following this and other approaches (Grasso et al., 1983) , before a definite answer can be given concerning the existence and meaning of a physiological IFN response.
